Biomaterial Injection Combines T Cell and Cancer Vaccine Treatments |
Researchers at the Harvard Wyss Institute have developed an anti-cancer biomaterial treatment that combines adoptive T cell therapy and cancer vaccine technology to treat solid tumors. The researchers have called their technique SIVET, which…
Continue Reading